Home › Breast Cancer › Washington › Vancouver
Breast Cancer clinical trials in Vancouver, WA
4 studies for Breast Cancer are looking for participants at sites in and around Vancouver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- PeaceHealth Southwest Medical Center, Vancouver
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
RecruitingPhase 2
- Northwest Cancer Specialists, Vancouver
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RecruitingPhase 3
- Clinical Trial Site, Vancouver
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RecruitingPhase 3
- Legacy Cancer Institute Medical Oncology and Day Treatment, Vancouver
- Legacy Salmon Creek Hospital, Vancouver
About Breast Cancer
Breast cancer is a cancer that starts in the breast tissue, when cells change and grow out of control. These extra cells can form a mass called a tumor.
More about Breast Cancer on MedlinePlus
Breast Cancer trials in other cities
- New York City, NY134 studies
- Houston, TX126 studies
- Boston, MA111 studies
- Nashville, TN80 studies
- Los Angeles, CA72 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Durham, NC63 studies
- Queens, NY63 studies
- Chicago, IL58 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Other studies in Vancouver
- Non-Small Cell Lung Cancer9 studies
- Lung Cancer7 studies
- Colorectal Cancer6 studies
- Prostate Cancer4 studies
- Metastatic Cancer4 studies
- Pancreatic Cancer4 studies
- Ulcerative Colitis3 studies
- Crohn's Disease3 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.